Received Jun 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Never received second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient. Previously administered products included Shingrix (received a Shingrix vaccine 3 and 1/2 years ago in 12/2021). The patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: Never received second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 11-JUN-2025 Pharmacist reported that a male patient received a Shingrix vaccine 3 and 1/2 years ago in 12/2021. Never received second dose and patient wanted to finish series if possible. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.